Skip to main content
TS Holdings logo

TS Holdings — Investor Relations & Filings

Ticker · 2887 ISIN · TW0002887007 LEI · 254900NDEO99JV07HK17 TW Financial and insurance activities
Open in API
Filings indexed 3,956 across all filing types
Latest filing 2025-11-27 Regulatory Filings
Country TW Taiwan
Listing TW 2887

About TS Holdings

https://www.tsholdings.com.tw/

Taishin Financial Holding Co., Ltd. is a comprehensive group that coordinates a diverse range of activities through its specialized subsidiaries. The organization provides retail and corporate banking, wealth management, securities brokerage, and life insurance services. Key entities within the group include Taishin International Bank, Taishin Securities, and Taishin Life Insurance. Its service portfolio features credit cards, asset management, and financial advisory, alongside specialized operations in equipment and vehicle leasing. The company serves a broad client base comprising individual consumers, small-to-medium enterprises, and large corporations. By leveraging an integrated platform, the group focuses on cross-selling synergies and digital service delivery to provide holistic solutions. Its operations extend to international leasing markets, supporting its strategic focus on diversified revenue streams and operational scale.

Recent filings

Filing Released Lang Actions
公告本公司將於114年11月28日受邀參加由台新證券主辦114年第三季法人說明會。
Regulatory Filings Classification · 95% confidence The document is a short announcement (662 characters) stating that the company will participate in a third quarter investor presentation hosted by a securities firm. It provides the date, time, and format (online) of the event but does not contain any financial data or detailed presentation content. It explicitly mentions that full financial and business information can be found elsewhere. This matches the description of an Investor Presentation (IP) announcement rather than the presentation itself. However, since the document is only an announcement of the event and does not include the presentation materials or detailed financials, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about the event, not the presentation itself or a report.
2025-11-27 Chinese
114年第3季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a tabular financial disclosure showing investment details in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period and prior year-end. It references accounting standards for financial reporting but does not contain a full financial report or comprehensive financial statements. The document length is short (1094 characters), and it appears to be a regulatory disclosure of investment information rather than a full annual or interim report. There is no indication of it being an announcement of a report publication, nor is it a certification or management discussion. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory disclosure of investment data without the depth or format of a full financial report or other specific filing types.
2025-11-26 Chinese
114年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning the company's investments in mainland China. It includes specific financial figures, investment methods, and regulatory approval limits. The content is focused on investment details rather than a narrative report or announcement. The document length is 2079 characters, which is relatively short but contains substantive financial data. It does not appear to be an announcement of a report publication or a certification. The nature of the data aligns with a Regulatory Filing (RNS) as it is a compliance disclosure related to investment activities and regulatory limits, without being a full annual or interim report, audit report, or other specific report types. Therefore, the best classification is Regulatory Filings (RNS).
2025-11-26 Chinese
本公司代子公司新光人壽公告董事會代行股東臨時會 重要決議事項
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (2887 台新新光金) regarding an important resolution made by the board acting on behalf of a shareholders' extraordinary meeting. The key content is about the approval to stop public issuance and proceed with dissolution as of the merger base date. The document is brief (525 characters) and serves as a regulatory announcement of a corporate action rather than a full report or detailed financial disclosure. It does not contain financial statements, audit information, or detailed management discussion. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about corporate decisions.
2025-11-25 Chinese
本公司代子公司新光人壽公告董事會決議通過 停止公開發行暨辦理解散案
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement from a listed company (2887 台新新光金) regarding a board resolution passed by its subsidiary 新光人壽保險股份有限公司 to stop public issuance and proceed with dissolution. It references approval by the Financial Supervisory Commission and merger details. The content is an official notice about corporate actions affecting share issuance and company status, not a full report or financial statement. The document length is short (897 characters) and it serves as a formal announcement of a corporate event rather than a detailed report or financial disclosure. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as stopping public issuance and dissolution.
2025-11-25 Chinese
本公司代子公司新光人壽公告金融監督管理委員會核准新光 人壽與台新人壽合併案
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (2887 台新新光金) about the approval by the Financial Supervisory Commission of the merger between its subsidiary 新光人壽 and 台新人壽. It includes details such as the date of the event, the relationship between the companies, and references to regulatory procedures. The document is short (857 characters) and serves as an official announcement of a regulatory approval related to a merger, but it does not contain the merger documents themselves or detailed financial data. It is not a full merger filing (MA) or a detailed M&A announcement (TAR), but rather a regulatory announcement about the approval. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-11-25 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.